{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:55:00Z","timestamp":1790747700300,"version":"4.1.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Medical treatment and endovascular therapy are widely employed in the management of symptomatic intracranial atherosclerotic stenosis, however, the comparative effectiveness of these treatment modalities remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched major Chinese and English databases to identify randomized controlled trials (RCTs) comparing four different endovascular modalities against other comparable non-endovascular therapies for patients with symptomatic intracranial atherosclerotic stenosis (sICAS). Eligible participants were individuals who had experienced a transient ischemic attack (TIA) or non-disabling stroke within the preceding 12\u202fmonths. The literature search cutoff date was 11 January 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>For safety outcomes, the SUCRA ranking was as follows: medical treatment (MT) (SUCRA 90.1%)\u202f&amp;gt;\u202fdrug-coated balloons (DCB) (SUCRA 52.8%)\u202f&amp;gt;\u202fballoon dilatation angioplasty (BDA) (SUCRA 40.7%)\u202f&amp;gt;\u202fbare metal stents (BMS) (SUCRA 35.4%)\u202f&amp;gt;\u202fdrug-eluting stents (DES) (SUCRA 31.0%). MT exhibited a superior safety profile compared with BMS, with a statistically significant difference (RR\u202f=\u202f0.47; 95% CI: 0.31 to 0.72). For long-term outcomes, exploratory SUCRA probability rankings were as follows: BDA (SUCRA 86.7%)\u202f&amp;gt;\u202fDES (SUCRA 77.4%)\u202f&amp;gt;\u202fMT (SUCRA 23.8%)\u202f&amp;gt;\u202fBMS (SUCRA 12.1%), and between-treatment differences were not statistically significant across all interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In terms of short-term safety, BMS treatment strategies were significantly inferior to medical treatment (MT), while no statistically significant differences in safety were observed among the various endovascular treatment modalities. In terms of adverse events during long-term follow-up, between-treatment differences were not statistically significant. Despite relatively high SUCRA values for BDA and DES for long-term outcomes, these rankings should be interpreted cautiously given the lack of statistically significant inter-group differences. Further research is required to verify the performance of each endovascular treatment strategy about restenosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:ext-link>\n                      , CRD420251146704.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1848611","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:56:43Z","timestamp":1790744203000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of angioplasty, stents and conventional medical therapy for symptomatic intracranial atherosclerosis: a network meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Jiawei","family":"Wang","sequence":"first","affiliation":[{"name":"College of Clinical Medicine, China Medical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baogan","family":"He","sequence":"additional","affiliation":[{"name":"College of Clinical Medicine, China Medical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoufeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tianjin Huanhu Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"23","author":"Feigin","year":"2024","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e001164","DOI":"10.1136\/bmjno-2025-001164","article-title":"Intracranial atherosclerotic stenosis in Asia: a systematic scoping and rapid review of prevalence, frequency in ischaemic stroke and risk factors","volume":"7","author":"Navarro","year":"2025","journal-title":"BMJ Neurol Open"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1212\/WNL.0000000000200030","article-title":"Stroke prevention in symptomatic large artery intracranial atherosclerosis practice advisory: report of the AAN guideline subcommittee","volume":"98","author":"Turan","year":"2022","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1161\/STROKEAHA.123.043630","article-title":"Epidemiology, pathophysiology, and imaging of atherosclerotic intracranial disease","volume":"55","author":"Chen","year":"2024","journal-title":"Stroke"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1001609","DOI":"10.3389\/fneur.2022.1001609","article-title":"Recurrent stroke risk in intracranial atherosclerotic disease","volume":"13","author":"Ballout","year":"2022","journal-title":"Front Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"svn-2025-004419","DOI":"10.1136\/svn-2025-004419","article-title":"Endovascular treatment for symptomatic intracranial artery stenosis: current strategies and future challenges","author":"Guo","year":"2026","journal-title":"Stroke Vasc Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(13)62038-3","article-title":"Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial","volume":"383","author":"Derdeyn","year":"2014","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1001\/jama.2022.12000","article-title":"Effect of stenting plus medical therapy vs medical therapy alone on risk of stroke and death in patients with symptomatic intracranial stenosis: the CASSISS randomized clinical trial","volume":"328","author":"Gao","year":"2022","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jama.2024.12829","article-title":"Balloon angioplasty vs medical management for intracranial artery stenosis: the BASIS randomized clinical trial","volume":"332","author":"Sun","year":"2024","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamaneurol.2021.4804","article-title":"Comparison of drug-eluting stent with bare-metal stent in patients with symptomatic high-grade intracranial atherosclerotic stenosis: a randomized clinical trial","volume":"79","author":"Jia","year":"2022","journal-title":"JAMA Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/jnis-2024-022768","article-title":"Comparison of drug-coated balloon with bare-metal stent in patients with symptomatic intracranial atherosclerotic stenosis: the AcoArt sICAS randomized clinical trial","volume":"18","author":"Ma","year":"2026","journal-title":"J NeuroIntervent Surg"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.25259\/SNI_775_2025","article-title":"Elucidating the benefit of drug-eluting stent for symptomatic intracranial atherosclerotic stenosis: meta-analysis of randomized controlled trials","volume":"16","author":"Soetomo","year":"2025","journal-title":"Surg Neurol Int"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12975-021-00957-7","article-title":"Medical and endovascular treatments for intracranial atherosclerotic stenosis: a network meta-analysis","volume":"14","author":"Peng","year":"2023","journal-title":"Transl Stroke Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/jrsm.1058","article-title":"Network meta-analysis, electrical networks and graph theory","volume":"3","author":"R\u00fccker","year":"2012","journal-title":"Res Synth Methods"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"g1741","DOI":"10.1136\/bmj.g1741","article-title":"Reporting of results from network meta-analyses: methodological systematic review","volume":"348","author":"Bafeta","year":"2014","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1105335","article-title":"Stenting versus aggressive medical therapy for intracranial arterial stenosis","volume":"365","author":"Chimowitz","year":"2011","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5853\/jos.2018.00479","article-title":"Cerebrovascular drug-eluting stent versus bare-metal stent in the treatment of vertebral artery stenosis: a non-inferiority randomized clinical trial","volume":"21","author":"He","year":"2019","journal-title":"J Stroke"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.13638\/j.issn.1671-4040.2022.02.021","article-title":"Clinical study on endovascular stent intervention for symptomatic intracranial atherosclerotic stenosis","volume":"22","author":"Huang","year":"2022","journal-title":"Pract Clin J Integr Tradit Chin West Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e243860","DOI":"10.1148\/radiol.243860","article-title":"Stent-assisted angioplasty in symptomatic intracranial stenosis without adjacent branch atheromatous disease: a randomized trial with patients selected by using three-dimensional rotational angiography","volume":"316","author":"Ip","year":"2025","journal-title":"Radiology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"854226","DOI":"10.3389\/fneur.2022.854226","article-title":"Effect of a drug-eluting stent vs bare metal stent for the treatment of symptomatic intracranial and vertebral artery stenosis","volume":"13","author":"Si","year":"2022","journal-title":"Front Neurol"},{"key":"ref23","first-page":"32","article-title":"Long-term outcome of endovascular treatment for severe intracranial artery stenosis of anterior circulation","volume":"17","author":"Xiao","year":"2014","journal-title":"Chin J Pract Nerv Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jama.2015.1693","article-title":"Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial","volume":"313","author":"Zaidat","year":"2015","journal-title":"JAMA"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.jacc.2021.07.048","article-title":"Intracranial hemorrhage during dual antiplatelet therapy","volume":"78","author":"Ha","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3174\/ajnr.A6689","article-title":"Incidence and risk factors of in-stent restenosis for symptomatic intracranial atherosclerotic stenosis: a systematic review and meta-analysis","volume":"41","author":"Peng","year":"2020","journal-title":"Am J Neuroradiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.phrs.2014.12.003","article-title":"Endothelialization of drug eluting stents and its impact on dual anti-platelet therapy duration","volume":"93","author":"Habib","year":"2015","journal-title":"Pharmacol Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.jcin.2011.05.025","article-title":"Vascular inflammation and repair","volume":"4","author":"Inoue","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/neuros\/nyz337","article-title":"Submaximal angioplasty for symptomatic intracranial atherosclerotic disease: a meta-analysis of peri-procedural and long-term risk","volume":"86","author":"Stapleton","year":"2020","journal-title":"Neurosurgery"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e085533","DOI":"10.1136\/bmjopen-2024-085533","article-title":"Drug-eluting stents versus bare-metal stents for intracranial atherosclerotic stenosis: a systematic review and meta-analysis","volume":"14","author":"Gong","year":"2024","journal-title":"BMJ Open"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e003259","DOI":"10.1136\/svn-2024-003259","article-title":"DRug-coated balloon for endovascular treatment of sYmptOmatic intracraNial stenotic disease (DR. BEYOND): the protocol of a multicentre randomised trial","volume":"10","author":"Mo","year":"2025","journal-title":"Stroke Vasc Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/jnis-2024-021502","article-title":"Comparison of rescue intracranial stenting versus best medical treatment alone in acute refractory large vessel occlusion: study protocol for the PISTAR multicenter randomized trial","volume":"17","author":"Premat","year":"2025","journal-title":"J NeuroIntervent Surg"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e091152","DOI":"10.1136\/bmjopen-2024-091152","article-title":"Evaluation of safety and efficacy of intracranial self-expanding drug-eluting stents for symptomatic intracranial atherosclerotic stenosis: a prospective, multicentre, randomised controlled, superiority clinical trial protocol","volume":"14","author":"Zhu","year":"2024","journal-title":"BMJ Open"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1848611\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:56:45Z","timestamp":1790744205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1848611\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":34,"alternative-id":["10.3389\/fneur.2026.1848611"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1848611","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1848611"}}